MedPath

High Molecular Weight Hyaluronic Acid, α-lipoic Acid, Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion

Not Applicable
Completed
Conditions
Abortion, Spontaneous
Registration Number
NCT05449171
Lead Sponsor
Lo.Li.Pharma s.r.l
Brief Summary

The study aims to verify if the association of high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D, reduces the risk of miscarriage in patients at risk.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • two or more previous spontaneous first trimester abortions without apparent risk factors (idiopathic polyabortion)
  • Endocrinopathies
  • Autoimmune diseases
  • Thrombophililic or coagulation diseases
Exclusion Criteria
  • Multiple pregnancies
  • Presence of genetic abnormalities of one or both partners leading to increased risk of fetal aneuploidies
  • Presence of Mullerian abnormalities in the uterus
  • Symptoms present at recruitment such as pelvic pain or metrorrhagia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of metrorrhagia and/or pelvic pain in the first trimester of gestation.3 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dipartimento di Neuroscienze e Scienze riproduttive ed odontostomatologiche

🇮🇹

Napoli, Italy

Dipartimento di Neuroscienze e Scienze riproduttive ed odontostomatologiche
🇮🇹Napoli, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.